Background: Intravenous immunoglobulin (IVIG) is an immunomodulating agent that has
several actions. The aim of this study was to investigate the indications of IVIG according to …

Neonatal sepsis remains a significant global problem with little progress made despite major
efforts. At present, there is a lack of an accepted international consensus on the definition …

Background: The problem of neonatal sepsis is enormous in India and many hospital-based
studies have revealed an incidence of 30/1000 live births. Objectives: The objectives of this …

Background Treatment effects differ across patients. To guide selection of treatments for
patients, it is essential to acknowledge these differences and identify moderators or …

Background Neonatal sepsis is occasionally associated with abnormal plasma glucose
level, but data in full-term and late-preterm neonates is limited. Our aim was to determine …

Biomarkers that target pathogen products using molecular assays are an expanding field,
but have not surpassed the use of standard microbial cultures in infants evaluated for sepsis …

Local and systemic infections are a significant cause of morbidity and mortality among
immunocompromised children, including but not limited to patients with hematologic and …

INTRODUCCIÓN 1 1.1 Definición de sepsis 1 1.2 Epidemiología 6 1.2. 1 Incidencia 6 1.2. 2
Mortalidad 7 1.2. 3 Evolución 8 1.3 Etiología 8 1.4 Fisiopatología 9 1.5 Clínica 18 1.5. 1 …

Sepsis is a life-threatening organ dysfunction induced after the dysregulated host response
to an infectious microbial insult. Despite the existing progress of our understanding of the …

This chapter discusses the information regarding neonatal susceptibility to, and acquisition
of infection, the organisms commonly implicated and investigation and treatment modalities …